These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12535388)

  • 21. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes.
    Salam RA; Das JK; Dojo Soeandy C; Lassi ZS; Bhutta ZA
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009982. PubMed ID: 26059051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour.
    Alfirevic Z; Devane D; Gyte GM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006066. PubMed ID: 16856111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early versus late discontinuation of oxygen in preterm or low birth weight infants.
    Askie LM; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2001; (4):CD001076. PubMed ID: 11687095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Operative versus conservative management for 'fetal distress' in labour.
    Hofmeyr GJ; Kulier R
    Cochrane Database Syst Rev; 2000; (2):CD001065. PubMed ID: 10796236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiotocography for antepartum fetal assessment.
    Pattison N; McCowan L
    Cochrane Database Syst Rev; 2000; (2):CD001068. PubMed ID: 10796239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy.
    Tuffnell DJ; West J; Walkinshaw SA
    Cochrane Database Syst Rev; 2003; (3):CD003395. PubMed ID: 12917965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral beta-blockers for mild to moderate hypertension during pregnancy.
    Magee LA; Duley L
    Cochrane Database Syst Rev; 2000; 2003(4):CD002863. PubMed ID: 11034777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Buchanan SL; Crowther CA; Levett KM; Middleton P; Morris J
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004735. PubMed ID: 20238332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal glucose administration for facilitating tests of fetal wellbeing.
    Tan KH; Sabapathy A
    Cochrane Database Syst Rev; 2001; (4):CD003397. PubMed ID: 11687202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal hyperoxygenation in the treatment of intrauterine growth retardation.
    Battaglia C; Artini PG; D'Ambrogio G; Galli PA; Segre A; Genazzani AR
    Am J Obstet Gynecol; 1992 Aug; 167(2):430-5. PubMed ID: 1497047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Near-infrared spectroscopy for fetal assessment during labour.
    Mozurkewich E; Wolf FM
    Cochrane Database Syst Rev; 2000; 2000(3):CD002254. PubMed ID: 10908536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calling into question the future of hyperoxygenation in pregnancy.
    McHugh A; El-Khuffash A; Franklin O; Breathnach FM
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():93-97. PubMed ID: 33421817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does maternal hyperoxygenation result in fetal oxygenation?
    Fruchter O
    Am J Obstet Gynecol; 1993 Dec; 169(6):1657-8. PubMed ID: 8267087
    [No Abstract]   [Full Text] [Related]  

  • 34. Prenatal therapy for fetal growth restriction.
    Figueroa R; Maulik D
    Clin Obstet Gynecol; 2006 Jun; 49(2):308-19. PubMed ID: 16721109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal Hemodynamic Response to Maternal Oxygenation in Normal and Complicated Pregnancies.
    Deng Y; Jin Y; Xu R; Zeng S
    Ultraschall Med; 2021 Dec; 42(6):607-613. PubMed ID: 32971542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized controlled trials.
    Mardones-Santander DF; Rosso DP; Uiterwaal D; Marshall DG
    Eur J Clin Nutr; 1999 Dec; 53(12):970-2. PubMed ID: 10602356
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy for intrauterine growth restriction: current options and future directions.
    Pollack RN; Yaffe H; Divon MY
    Clin Obstet Gynecol; 1997 Dec; 40(4):824-42. PubMed ID: 9429797
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrapartum Maternal Oxygen Supplementation-Friend or Foe?
    Pammi M; Clark SL; Shamshirsaz AA
    JAMA Pediatr; 2021 Mar; 175(3):236-237. PubMed ID: 33393989
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis.
    Liu Y; Un EM; Bai Y; Chan MK; Zeng LX; Lei SL; Li J; Ung COL
    J Pharm Pharm Sci; 2024; 27():13206. PubMed ID: 39211421
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.